Skip to main content
FOUNDAYO DENIAL GUIDE

Foundayo Denied by Insurance? What It Means & What to Do Next

You have 180 days to appeal — and 65%+ succeed with proper documentation.

Last updated October 6, 2026 · Key facts verified October 5, 2026
Below you'll find:
  • Why your Foundayo was denied and what it means
  • Your immediate next steps (you have 180 days)
  • How to appeal — 65%+ succeed with proper documentation
Foundayo product

This happens to most people

You're Not Alone

62%of GLP-1 prior authorizations are denied initially[1]
81%of large employers don't cover GLP-1s for weight loss[2]
65%+of appeals succeed with proper documentation[3]

Getting denied doesn't mean the answer is no forever. It means the insurer needs more information — or you need to push back. You have the right to appeal, and complete documentation that addresses the specific denial reason puts your appeal on stronger footing.

Rated excellent★★★★★Trustpilot

Your GLP-1 coverage,
denied approved


Honest Care helps patients fight back:
Evidence-backed appeal letters — plus personalized guidance to appeal with confidence.

✓ Free Templates✓ Premium Support Available

See what patients are saying on
Rated excellent★★★★★Trustpilot
Your GLP-1 coverage,
denied approved

Honest Care helps patients fight back:

Evidence-backed appeal letters — plus personalized guidance to appeal with confidence.

Free TemplatesPremium Support Available
★★★★★

"I found Honest Care online and was very impressed with the letter... the appeal worked!"

— Anne B.
★★★★★

"My Appeal was approved the next day. Thank you Honest Care!"

— Cindy R.

Find your denial reason below

Why Were You Denied?

Your denial letter should state the reason. Click the one that matches — each has a different appeal strategy:

What Insurers Look For in Approvals

  • BMI documentation — Recent measurements (ideally <6 months)
  • Comorbidity codes — Type 2 diabetes, hypertension, sleep apnea, etc.
  • Prior medication history — What you've tried before and why it failed
  • Lifestyle modification proof — Diet/exercise programs, dietitian visits
  • Physician letter of medical necessity — Explaining why Foundayo specifically

Missing any of these is a common reason for denial. Your appeal should address the gap.

3 immediate steps

What to Do Right Now

1

Find Your Denial Letter

Look for the specific reason they denied you. It's usually in a paragraph that starts with "Your request was denied because..." This determines your appeal strategy.

2

Note Your Deadline

You have 180 days from the denial date to file an internal appeal (under most plans). Missing this deadline typically forfeits your right to appeal. Mark it on your calendar.

3

Start Your Appeal

Honest Care writes your personalized appeal letter for free. We'll ask a few questions about your situation and denial, then create an insurer-ready letter.

Get Free Appeal Letter →
⚠️
Don't Wait: The 180-day clock started the day you got your denial letter. The sooner you appeal, the sooner you may be able to start your medication.

Need Foundayo while your appeal is processing? Many patients use LillyDirect or other affordability options to start treatment while waiting for insurance approval.

Plan won't cover Foundayo at all? Other GLP-1s like Wegovy or Mounjaro may have different coverage on your plan. Compare Foundayo alternatives →

The numbers are on your side

Appeals Actually Work

Appeals Success Rate
65%+

With proper documentation[3]

People Who Appeal
<1%

Most people never file an appeal[4]

Many insurers expect patients not to appeal — which is why taking action matters. The appeal process exists for a reason, and it often works.

Common questions after a denial

Quick Answers

Yes. You have several options: (1) Appeal the denial — 65%+ of appeals succeed with proper documentation. (2) Pay cash — LillyDirect offers Foundayo at $149–$299/month (see current pricing). (3) Use the savings card — If your appeal succeeds and you have commercial insurance coverage, pay as low as $25/month with the manufacturer savings card. Without coverage, the savings card reduces cost to LillyDirect self-pay levels ($149–$299/month), not $25. The savings card excludes Medicare, Medicaid, and government programs.

You typically have 180 days from the date on your denial letter to file an internal appeal (check your plan documents for exact deadlines). After that, you may lose your right to appeal. Mark your calendar and don't wait.

Good. 65%+ of appeals succeed when you have proper documentation (AMA/KFF data). The key is addressing the specific reason you were denied and providing the right evidence.

Yes. LillyDirect offers Foundayo at reduced cash prices without insurance (see current pricing). This lets you start treatment while your appeal is pending. If your appeal succeeds, some plans may reimburse part of your out-of-pocket costs.

WHAT'S CHANGING

Foundayo Denials: 2026 Outlook

2026: Mixed Outlook for Coverage

While more employers are adding GLP-1 coverage (estimated 25%+ in 2026, up from 19%), denial rates remain high due to stricter PA requirements and cost management strategies.

CMS Prior Authorization Reform

The CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F) takes effect in 2026:

  • Faster decisions: From January 1, 2026, Medicare Advantage, Medicaid and CHIP must decide medical prior authorizations within 7 days (72 hours if urgent); the rule excludes drugs (so it doesn't change Foundayo prior authorization timelines)
  • Transparency: Insurers must disclose denial reasons clearly
  • Digital integration: PA requests through electronic health records

If Appeals Fail: Cash Pay Option

For patients who exhaust appeal options, LillyDirect offers Foundayo at reduced cash prices — significantly lower than standard retail.

See current Foundayo pricing options →

Denied Another GLP-1?

Appeal strategies are similar across GLP-1 medications:

References

  1. KFF Health News. "Use of GLP-1 Agonists, Prior Authorization, and Spending in Medicare Part D." Kaiser Family Foundation, 2024. Note: Denial rate reflects GLP-1 medications broadly; Foundayo-specific data is still emerging as the drug launched April 2026. KFF GLP-1 Prior Authorization Report
  2. Mercer National Survey of Employer-Sponsored Health Plans. "GLP-1 Coverage Trends." 2024. Mercer 2024 National Survey
  3. American Medical Association / Kaiser Family Foundation. Prior authorization appeal success data. Note: AMA reports 80%+ for Medicare Advantage; we use a conservative 65%+ estimate for commercial insurance plans. ama-assn.org
  4. Kaiser Family Foundation. "Claims Denials and Appeals in ACA Marketplace Plans." KFF Analysis, 2023. kff.org

Disclaimer

The information on this page is for educational and informational purposes only and is not intended as medical advice. Honest Care does not provide medical diagnosis, treatment, or individualized recommendations. Always seek the advice of your physician or other qualified healthcare professional regarding any medical condition or treatment.

While this content has been reviewed for accuracy and balance, new evidence may emerge after publication. Drug availability, indications, and insurance coverage can change over time. Honest Care makes no warranties as to completeness or currentness of the information and is not responsible for decisions made based on this content.